Affinage

DNAJC15

DnaJ homolog subfamily C member 15 · UniProt Q9Y5T4

Length
150 aa
Mass
16.4 kDa
Annotated
2026-06-09
27 papers in source corpus 14 papers cited in narrative 14 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DNAJC15 (MCJ) is a mitochondrial inner-membrane J-domain co-chaperone that acts as an endogenous brake on oxidative metabolism, anchored in the inner membrane with its C-terminal J domain facing the matrix (PMID:23263864). It functions in two coupled capacities: as a negative regulator of the respiratory chain, where it interacts preferentially with Complex I and interferes with the assembly of respiratory supercomplexes, such that its loss raises Complex I activity, membrane potential, and ATP output (PMID:23530063, PMID:27234056); and as a J co-chaperone of the TIM23 pre-protein import motor, forming a subcomplex with MAGMAS and stimulating the ATPase activity of mtHsp70/mortalin to drive pre-protein import (PMID:23263864, PMID:41760807). Through its respiratory restraint, DNAJC15 governs metabolic programs across tissues — its silencing enhances fatty acid β-oxidation and protects against hepatic steatosis and fibrosis (PMID:32620763), shapes CD8+ T cell effector and memory metabolism (PMID:27234056), and limits UCP1-independent thermogenesis in brown adipose tissue via an eIF2α-dependent stress response (PMID:39805849). DNAJC15 also couples mitochondria to cell death, recruiting cyclophilin D to promote permeability transition pore opening and apoptosis (PMID:24603329) and driving lipid peroxidation and ferroptosis in cancer cells (PMID:39809321). Its abundance is tightly controlled at multiple levels: epigenetically by CpG-island methylation within its first exon (PMID:14729589) and by transcriptional repression via ETV7 (PMID:30025229), post-translationally by SAMe-dependent lysine methylation in concert with MATα1 (PMID:38385082), and by stress-induced cleavage by OMA1 followed by AFG3L2-mediated degradation (PMID:41760807).

Mechanistic history

Synthesis pass · year-by-year structured walk · 14 steps
  1. 2004 High

    Established how DNAJC15 expression is set in a cell-type-specific manner, identifying an epigenetic switch rather than transcription-factor control as the primary determinant.

    Evidence Bisulfite sequencing and ChIP for histone acetylation across epithelial, lymphocyte, and fibroblast cell types

    PMID:14729589

    Open questions at the time
    • Does not identify the trans factors directing methylation
    • Does not link expression level to mitochondrial function
  2. 2012 High

    Defined the molecular activity of DNAJC15 as a J co-chaperone of the TIM23 import motor, answering what its J domain does biochemically.

    Evidence Submitochondrial fractionation, reciprocal Co-IP with MAGMAS/TIM23, in vitro mtHsp70 ATPase assay, yeast Tim14 complementation, and import assay in MCJ-depleted mitochondria

    PMID:23263864

    Open questions at the time
    • Does not reconcile import-motor role with respiratory regulation
    • Stoichiometry within the import motor not resolved
  3. 2013 High

    Established DNAJC15 as a negative regulator of the respiratory chain acting through Complex I and supercomplex assembly, defining its core metabolic function.

    Evidence Subcellular fractionation, Co-IP with Complex I, and respiratory assays in MCJ-deficient cells and mice

    PMID:23530063

    Open questions at the time
    • Structural basis for supercomplex interference unknown
    • How Complex I binding relates to the J/ATPase activity not defined
  4. 2014 Medium

    Connected DNAJC15 to regulated cell death, showing it couples the permeability transition machinery to apoptotic signaling.

    Evidence Gain/loss-of-function with MPTP opening assays and Co-IP with cyclophilin D under cisplatin treatment

    PMID:24603329

    Open questions at the time
    • Single lab without reciprocal validation of the CypD interaction
    • Relationship between MPTP role and respiratory function unclear
  5. 2016 High

    Extended the respiratory-brake model to immune physiology, showing DNAJC15 tunes CD8+ T cell metabolism and memory formation in vivo.

    Evidence Seahorse metabolic profiling, supercomplex native gels, MCJ-KO mice, cytokine assays, and influenza infection

    PMID:27234056

    Open questions at the time
    • Mechanism linking ATP accumulation to selective IFN-γ secretion not resolved
  6. 2017 High

    Showed DNAJC15 as a pharmacological node in drug-induced liver injury, where xenobiotic stress acts through MCJ to disrupt supercomplexes.

    Evidence Supercomplex native gels, ROS/ATP measurement, and siRNA MCJ inhibition in a mouse APAP liver injury model

    PMID:29233977

    Open questions at the time
    • How APAP engages MCJ molecularly not defined
  7. 2018 Medium

    Identified a transcriptional repressor controlling DNAJC15 in cancer, linking its silencing to chemoresistance.

    Evidence ChIP/promoter binding of ETV7 at the DNAJC15 promoter, ETV7 overexpression, drug efflux assays, and DNAJC15 rescue in breast cancer cells

    PMID:30025229

    Open questions at the time
    • Mechanistic link between DNAJC15 and efflux pumps only partially rescued
    • Single lab
  8. 2019 Medium

    Linked DNAJC15 expression to glycolytic state and caspase-3-dependent T cell fate, integrating metabolic input with apoptotic output.

    Evidence MCJ-KO T cells, caspase-3 activity assays, glycolysis measurements, and methylation analysis in IL-2 vs IL-15 cultures

    PMID:30915331

    Open questions at the time
    • Direct mechanism by which MCJ promotes caspase-3 activity unclear
    • Single lab
  9. 2020 High

    Demonstrated DNAJC15 silencing as a therapeutic strategy in fatty liver disease, validating its β-oxidation-restraining role in hepatocytes.

    Evidence Nanoparticle/GalNAc siRNA silencing in vivo, β-oxidation and lipid assays, and fibrosis scoring across NASH models

    PMID:32620763

    Open questions at the time
    • Long-term consequences of chronic MCJ loss on import function not assessed
  10. 2024 Medium

    Revealed post-translational control of DNAJC15 via SAMe and lysine methylation, adding a metabolite-sensing layer to its regulation.

    Evidence Co-IP of MCJ with MATα1 in liver mitochondria, MS identification of lysine methylation, MAT1A overexpression/SAMe treatment, and MATα1-KO

    PMID:38385082

    Open questions at the time
    • Functional consequence of specific methylation sites not established
    • Single lab
  11. 2025 Medium

    Showed DNAJC15 drives ferroptosis and chemosensitivity in cancer when elevated, defining a context-dependent pro-death role.

    Evidence DNAJC15 overexpression, lipid peroxidation assays, Ferrostatin-1 rescue, and cisplatin sensitivity in ovarian cancer cells

    PMID:39809321

    Open questions at the time
    • Molecular trigger linking MCJ to lipid peroxidation unknown
    • Single lab
  12. 2025 High

    Established DNAJC15 as a restraint on UCP1-independent thermogenesis, identifying eIF2α stress signaling as the required effector.

    Evidence MCJ-KO mice, EM of mitochondrial morphology, proteomics, in vivo CRISPR deletion of eIF2α, and thermogenesis measurement

    PMID:39805849

    Open questions at the time
    • How MCJ loss engages the eIF2α stress response mechanistically not defined
  13. 2026 High

    Defined the stress-induced proteolytic turnover of DNAJC15 and tied its loss to import failure and ER-localized UPR.

    Evidence OMA1 cleavage and AFG3L2 protease assays, import assays in DNAJC15-deficient cells, and ER stress/UPR reporters

    PMID:41760807

    Open questions at the time
    • Stress signals that activate OMA1 cleavage of MCJ not enumerated
  14. 2026 Medium

    Showed that high DNAJC15 reroutes electron flux to Complex II to support aggressive cancer metabolism, refining its role beyond simple Complex I inhibition.

    Evidence MCJ overexpression, Seahorse flux analysis, Complex I/II activity assays, lipid measurements, and proliferation/migration assays

    PMID:41484063

    Open questions at the time
    • Mechanism of preferential Complex II routing unresolved
    • Single lab

Open questions

Synthesis pass · forward-looking unresolved questions
  • How DNAJC15's dual roles as TIM23 import co-chaperone and Complex I/supercomplex regulator are physically and functionally coordinated at the inner membrane remains unresolved.
  • No structural model of MCJ bound to Complex I or the import motor
  • Whether import and respiratory functions are mutually exclusive states is unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 3 GO:0044183 protein folding chaperone 2 GO:0140096 catalytic activity, acting on a protein 1
Localization
GO:0005739 mitochondrion 3
Pathway
R-HSA-1430728 Metabolism 4 R-HSA-392499 Metabolism of proteins 2 R-HSA-5357801 Programmed Cell Death 2 R-HSA-8953897 Cellular responses to stimuli 2
Complex memberships
TIM23 import motor

Evidence

Reading pass · 14 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2013 MCJ/DnaJC15 localizes to the mitochondrial inner membrane and interacts preferentially with Complex I of the electron transport chain, where it impairs the formation of respiratory supercomplexes and functions as a negative regulator of the respiratory chain. Loss of MCJ leads to increased Complex I activity, mitochondrial membrane potential, and ATP production. Subcellular fractionation, Co-immunoprecipitation, functional respiratory chain assays in MCJ-deficient cells/mice Molecular and cellular biology High 23530063
2012 MCJ is anchored in the mitochondrial inner membrane with its C-terminal J domain facing the matrix. It forms a stable subcomplex with MAGMAS, a component of the mitochondrial import motor, and both interact with core components of the TIM23 pre-protein translocase. The recombinant soluble MCJ domain stimulates the ATPase activity of mtHsp70 (mortalin), the central component of the TIM23 import motor, and this stimulation is counteracted by MAGMAS. Loss of MCJ impairs pre-protein import into mitochondria, and MCJ can functionally substitute for Tim14, the essential J co-chaperone of the yeast import motor. Submitochondrial fractionation, Co-immunoprecipitation, in vitro ATPase assay with recombinant proteins, yeast complementation assay, import assay in MCJ-depleted mitochondria Human molecular genetics High 23263864
2014 DnaJC15 overexpression promotes mitochondrial permeability transition pore (MPTP) opening and apoptosis upon cisplatin treatment, while reduced DnaJC15 suppresses MPTP activation. DnaJC15 exerts its pro-apoptotic function through cyclophilin D (CypD), recruiting and coupling CypD with the mitochondrial permeability transition machinery. Overexpression and knockdown of DnaJC15 in cells, MPTP opening assays, Co-immunoprecipitation with CypD, cisplatin treatment with apoptosis readouts Cell death & disease Medium 24603329
2016 MCJ acts as an endogenous brake for mitochondrial respiration in CD8+ T cells by interfering with formation of electron transport chain respiratory supercomplexes. MCJ deficiency enhances oxidative phosphorylation and subcellular ATP accumulation, which selectively increases secretion (but not expression) of IFN-γ. MCJ also modulates effector CD8+ T cell metabolism during the contraction phase, resulting in superior memory T cell formation. Metabolic profiling (Seahorse), supercomplex analysis, MCJ-deficient mice, cytokine secretion assays, influenza infection model Immunity High 27234056
2004 Cell type-specific expression of MCJ is controlled by methylation of a CpG island within its first exon (not the promoter). The CpG island is methylated and MCJ is not expressed in epithelial cells, but unmethylated and expressed in lymphocyte or fibroblast cells. CpG island methylation is associated with loss of histone acetylation at both the island and the promoter region, indicating methylation-directed chromatin remodeling leads to gene inactivation. Bisulfite sequencing, RT-PCR, chromatin immunoprecipitation (ChIP) for histone acetylation marks Carcinogenesis High 14729589
2017 APAP (acetaminophen) treatment interferes with formation of mitochondrial respiratory supercomplexes via MCJ, leading to decreased ATP production and increased ROS generation. In vivo inhibition of MCJ expression protects the liver from APAP-induced injury. Supercomplex native gel analysis, ROS and ATP measurement, siRNA-mediated MCJ inhibition in mouse APAP liver injury model Nature communications High 29233977
2020 MCJ is an endogenous negative regulator of respiratory chain Complex I in hepatocytes. Decreasing MCJ expression (via nanoparticle- or GalNAc-formulated siRNA) enhances hepatocyte capacity for β-oxidation of fatty acids, reduces lipid accumulation, and decreases hepatocyte damage and fibrosis in multiple NASH mouse models. siRNA-mediated MCJ silencing in vivo (nanoparticle/GalNAc formulations), β-oxidation assay, lipid quantification, histological fibrosis scoring in NASH mouse models Nature communications High 32620763
2018 ETV7, a transcriptional repressor of the ETS family induced by doxorubicin, directly binds the DNAJC15 promoter and represses DNAJC15 expression, leading to doxorubicin resistance in breast cancer cells. ETV7-mediated resistance involves increased doxorubicin efflux via nuclear pumps, which is partially rescued by DNAJC15 upregulation. ChIP/promoter binding assay for ETV7 at DNAJC15 promoter, ETV7 overexpression with DNAJC15 expression measurement, drug efflux assays, DNAJC15 rescue experiments Neoplasia Medium 30025229
2019 Induction of glycolysis in CD8+ T cells upregulates MCJ expression, and MCJ acts synergistically with glycolysis to promote caspase-3 activity. MCJ-deficient effector CD8+ T cells show reduced glycolysis and considerably less active caspase-3 compared to wild-type cells. In non-glycolytic IL-15-cultured CD8+ T cells, MCJ expression is repressed by methylation, paralleling reduced caspase-3 activity and increased survival. MCJ-deficient mouse CD8+ T cells, caspase-3 activity assays, glycolysis measurements, methylation analysis of MCJ locus in IL-2 vs IL-15 cultured T cells Frontiers in cell and developmental biology Medium 30915331
2024 S-adenosylmethionine (SAMe) negatively regulates MCJ expression in the liver. MCJ is methylated at lysine residues and interacts with MATα1 (methionine adenosyltransferase alpha 1) within liver mitochondria, likely to facilitate its methylation. Deficiency in MATα1 leads to MCJ upregulation, while MAT1A overexpression and SAMe treatment reduce MCJ expression. Co-immunoprecipitation of MCJ with MATα1 in liver mitochondria, mass spectrometry identification of lysine methylation on MCJ, MAT1A overexpression, SAMe treatment, MATα1-KO model International journal of biological sciences Medium 38385082
2025 DNAJC15 overexpression in ovarian cancer cells induces lipid peroxidation and ferroptosis, increasing sensitivity to cisplatin. Inhibition of lipid peroxidation with Ferrostatin-1 reduces ferroptosis vulnerability and recovers cisplatin resistance, establishing a mechanistic link between DNAJC15, ferroptosis induction, and chemosensitivity. DNAJC15 overexpression, lipid peroxidation assays, Ferrostatin-1 rescue experiments, cisplatin sensitivity assays in ovarian cancer cells Open biology Medium 39809321
2026 The mitochondrial protease OMA1 cleaves DNAJC15, promoting its degradation by the m-AAA protease AFG3L2 under cellular stress conditions. Loss of DNAJC15 impairs mitochondrial protein import and restricts OXPHOS biogenesis. Non-imported mitochondrial preproteins accumulate at the endoplasmic reticulum, inducing an unfolded protein response. OMA1 cleavage assay, AFG3L2 protease assay, mitochondrial protein import assay in DNAJC15-deficient cells, ER stress/UPR reporter assays Nature structural & molecular biology High 41760807
2025 Absence of MCJ in brown adipose tissue (BAT) promotes thermogenesis even in the absence of UCP1. MCJKO mice show altered mitochondrial morphology consistent with BAT activation, and the eIF2α-mediated stress response is required for this enhanced thermogenesis, as in vivo CRISPR deletion of eIF2α in MCJKO mice abrogates the thermogenic phenotype. MCJKO mouse model, electron microscopy of mitochondrial morphology, proteomics, in vivo CRISPR deletion of eIF2α in MCJKO mice, thermogenesis measurement Nature communications High 39805849
2026 Elevated MCJ levels in cancer cells promote aggressive proliferative and migratory phenotypes by mediating a preferential rerouting of electron flux through Complex II (succinate dehydrogenase complex) rather than Complex I. This results in suppressed glycolysis, increased lipid accumulation and oxidation, maintained NADH levels, and preserved respiratory output despite Complex I uncoupling. MCJ overexpression in cancer cells, Seahorse metabolic flux analysis, Complex I/II activity assays, lipid accumulation and oxidation measurements, proliferation and migration assays Cell death & disease Medium 41484063

Source papers

Stage 0 corpus · 27 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2020 Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nature communications 114 32620763
2013 MCJ/DnaJC15, an endogenous mitochondrial repressor of the respiratory chain that controls metabolic alterations. Molecular and cellular biology 101 23530063
2017 The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. Nature communications 98 29233977
2016 Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus. Immunity 63 27234056
2004 Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Carcinogenesis 59 14729589
2005 Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy. Gynecologic oncology 56 15894365
2006 Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. International journal of cancer 51 16049974
2012 Methylation-controlled J-protein MCJ acts in the import of proteins into human mitochondria. Human molecular genetics 44 23263864
2018 ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells. Neoplasia (New York, N.Y.) 32 30025229
2014 Chaperoning mitochondrial permeability transition: regulation of transition pore complex by a J-protein, DnaJC15. Cell death & disease 27 24603329
2014 Characterization of pMC11, a plasmid with dual origins of replication isolated from Lactobacillus casei MCJ and construction of shuttle vectors with each replicon. Applied microbiology and biotechnology 23 24652065
2020 The mitochondrial negative regulator MCJ modulates the interplay between microbiota and the host during ulcerative colitis. Scientific reports 21 31953445
2024 Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies. Nature communications 19 38789421
2016 Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer. JCI insight 19 27275014
2021 Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury. JHEP reports : innovation in hepatology 18 33997750
2006 Endogenous retrovirus-related sequences provide an alternative transcript of MCJ genes in human tissues and cancer cells. Genes & genetic systems 13 17159294
2019 Glycolysis Induces MCJ Expression That Links T Cell Proliferation With Caspase-3 Activity and Death. Frontiers in cell and developmental biology 11 30915331
2015 The expression of CCN2, IQSEC, RSPO1, DNAJC15, RIPK2, IL13RA2, IRS1, and IRS2 genes in blood of obese boys with insulin resistance. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994) 9 26040030
2025 Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells. Open biology 8 39809321
2024 S-Adenosylmethionine Negatively Regulates the Mitochondrial Respiratory Chain Repressor MCJ in the Liver. International journal of biological sciences 5 38385082
2025 Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis. Nature communications 4 39805849
2025 MicroRNA-29a attenuates inflammation and fibrosis in an animal model of NASH through MCJ inhibition and hippo pathway regulation. European journal of pharmacology 3 40907687
2026 Stress adaptation of mitochondrial protein import by OMA1-mediated degradation of DNAJC15. Nature structural & molecular biology 2 41760807
2023 In Vivo and In Vitro Expression of iC1, a Methylation-Controlled J Protein (MCJ) in Bovine Liver, and Response to In Vitro Bovine Fatty Liver Disease Model. Animals : an open access journal from MDPI 1 36978641
2026 MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell death & disease 0 41484063
2022 Polyploidization affects the allelic variation of jasmonate-regulated protein Ta-JA1 belonging to the monocot chimeric jacalin (MCJ) family in wild emmer wheat. Gene 0 35306115
2021 The in vitro antiviral activity of Lacticaseibacillus casei MCJ protein-based metabolites on bovine viral diarrhea virus. Animal biotechnology 0 34495814

Missed literature

Know a paper Affinage missed for DNAJC15? Flag it for the maintainers and the community.

No submissions yet.